Inmune Bio (INMB) Prepaid Assets (2017 - 2026)

Inmune Bio has reported Prepaid Assets for 10 years, with the latest figure at $694000.0 in Q1 2026.

• Quarterly Prepaid Assets rose 235.27% year-over-year to $694000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $694000.0 (up 235.27% YoY) and the FY2025 annual result came in at $595000.0, up 79.76% from the prior year.
• Prepaid Assets advanced to $694000.0 in Q1 2026 per INMB's latest filing, from $595000.0 in the prior quarter.
• Over five years, Prepaid Assets peaked at $4.7 million in Q1 2022 and troughed at $23000.0 in Q1 2024.
• A 5-year average of $1.5 million and a median of $694000.0 in 2026 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 28664.29% in 2022, then plunged 99.29% in 2023.
• Over 5 years, Prepaid Assets stood at $4.0 million in 2022, then tumbled by 62.5% to $1.5 million in 2023, then slumped by 78.08% to $331000.0 in 2024, then surged by 79.76% to $595000.0 in 2025, then advanced by 16.64% to $694000.0 in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $694000.0, $595000.0, and $472000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.